ERBB2 and neoplasm: Given that the BsAb can crosslink PD1 on T cells and HER2 on tumor cells, we hypothesized that the BsAb may enhance tumor cell killing by bringing T cells into the proximity of tumor cells and potentially inducing PD1 synapse formation as seen in our previous study [39].